TD-5108, a selective 5-HT4 agonist, is consistently better than placebo regardless of response definition in patients with chronic constipation

Goldberg, M. R., Li, Y-P., Pitzer, K., Johanson, J. F., Mangel, A. W., & Kitt, M. M. (2008). TD-5108, a selective 5-HT4 agonist, is consistently better than placebo regardless of response definition in patients with chronic constipation. Gastroenterology, 134(4), A545-A545.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article

Development of a novel shared decision making aid for primary immunodeficiency diseases
Article

Community overdose surveillance
Article

Epigenetic biomarkers for smoking cessation